https://yestino.com/entities/ozempic-maker-novo-71ff9eEvery event involving Ozempic-maker Novoenhttps://yestino.com/events/ozempic-maker-novo-open-to-upgrading-us-listing-2df154https://yestino.com/events/ozempic-maker-novo-open-to-upgrading-us-listing-2df154Wed, 23 Sep 2026 04:00:29 GMTBoss Mike Doustdar says he sees ‘advantages’ in giving US investors direct access to Danish group’s stock Sources: Financial Times